NCT00004068View on ClinicalTrials.gov

Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

irinotecan hydrochloride

DRUG

temozolomide

PROCEDURE

conventional surgery

RADIATION

radiation therapy

Trial Locations (1)

38105-2794

Saint Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT00004068 - Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor | Biotech Hunter | Biotech Hunter